NPS PHARMACEUTICALS, INC.

Inactive Instrument

NPS Pharmaceuticals, Inc. Stock

Stocks

US62936P1030

Biotechnology & Medical Research

End-of-day quote Nasdaq Other stock markets
- ^USD	-

12/02/15	NPS Pharmaceuticals : Shire confident on 2015 after NPS deal, binge-eating drug approval	RE
26/01/15	NPS Pharmaceuticals : Shire shares jump as drug approval vindicates $5.2 billion NPS purchase	RE

Latest news : NPS Pharmaceuticals, Inc.

12/02/15	NPS Pharmaceuticals : Shire confident on 2015 after NPS deal, binge-eating drug approval	RE
26/01/15	NPS Pharmaceuticals : Shire shares jump as drug approval vindicates $5.2 billion NPS purchase	RE
15/01/15	Aegerion Pharmaceuticals : Exclusive: Top investors push Aegerion to oust CEO, consider sale - sources	RE
13/01/15	Alcoa : Wall St. falls; energy shares dragged down further by oil	RE
17/12/14	AbbVie : Shire considering bid for NPS Pharmaceuticals - Bloomberg	RE
02/06/14	NPS Pharmaceuticals : Shire secures $5 billion funding for NPS Pharma bid - The Times	RE

Press Releases: NPS Pharmaceuticals, Inc.

21/02/15	NPS Pharmaceuticals : Shire Completes Acquisition of NPS Pharma	PR
06/02/15	NPS Pharmaceuticals : Biotech Stocks Review - Arena Pharma, Amgen, NPS Pharma, ZIOPHARM Oncology, and Advaxis	PR
27/01/15	NPS PHARMACEUTICALS : INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of NPS Pharmaceuticals, Inc. (NPSP) Over the Proposed Sale of the Company to Shire PLC	BU
24/01/15	NPS Pharmaceuticals : FDA Approves Natpara® (parathyroid hormone) for Injection as an Adjunct to Calcium and Vitamin D to Control Hypocalcemia in Patients with Hypoparathyroidism	BU
17/01/15	NPS Pharmaceuticals : SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of NPS Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information	BU

More press releases

News in other languages: NPS Pharmaceuticals, Inc.

12/02/15	Shire : Hausse du résultat du T4, le titre monte
26/01/15	American Airlines : Les valeurs à suivre sur les marchés américains
26/01/15	USA-Les valeurs à suivre à Wall Street
13/01/15	Foundation Medicine : Wall Street clôture en baisse avec le pétrole
13/01/15	Wall Street finit en baisse avec le pétrole

Bio Therapeutic Drugs

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	ARGENX SE	-0.41%	+5.32%	+77.55%	+135.13%	59.1B
	WUXI APPTEC CO., LTD.	+2.32%	+5.03%	+75.26%	+92.31%	55.19B
	BIONTECH SE	+3.86%	+6.93%	-11.32%	-10.57%	24.67B
	INSMED INCORPORATED	+4.30%	+7.95%	+14.11%	+440.44%	24.19B
	WUXI BIOLOGICS (CAYMAN) INC.	+0.64%	+7.14%	+50.90%	-1.05%	19.69B
	GENMAB A/S	-1.43%	+7.33%	+41.02%	-28.95%	17.56B
	PHARMAESSENTIA CORPORATION	0.00%	+20.78%	+186.15%	+347.42%	16.22B
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+4.91%	+20.18%	+48.55%	-	14.84B
	EXELIXIS, INC.	+3.50%	+1.97%	+21.02%	+193.33%	14.04B
	Average	+1.96%	+8.57%	+55.91%	+146.01%	27.28B
	Weighted average by Cap.	+1.68%	+6.47%	+59.29%	+135.68%

See all sector performances

Company Profile

Employees

-

Sector

Biotechnology & Medical Research

More about the company

Google lets you customize your preferred sources.

G Google

Choose MarketScreener

G Google

Choose MarketScreener